AstraZeneca PLC (AZN)
90.20
+0.17
(+0.19%)
USD |
NASDAQ |
Dec 05, 15:41
Price Chart
Key Stats
| Price and Performance | |
|---|---|
| Market Cap | 279.66B |
| 52 Week High (Daily) | Upgrade |
| 52 Week Low (Daily) | Upgrade |
| All-Time High (Daily) | Upgrade |
| Year to Date Total Returns (Daily) | Upgrade |
| 1 Month Total Returns (Daily) | Upgrade |
| 1 Year Total Returns (Daily) | 37.68% |
| Valuation | |
| PE Ratio | 29.95 |
| PE Ratio (Forward) | Upgrade |
| PS Ratio | 4.849 |
| Price to Book Value | 6.094 |
| EV to EBITDA | Upgrade |
| Dividend | |
|---|---|
| Dividend | 0.515 |
| Dividend Yield (Forward) | Upgrade |
| Financials | |
| Revenue (5 Year Growth) | Upgrade |
| Revenue (Quarterly YoY Growth) | Upgrade |
| EPS Diluted (5 Year Growth) | Upgrade |
| EPS Diluted (Quarterly YoY Growth) | Upgrade |
| Debt to Equity Ratio | 0.7111 |
| Return on Equity | Upgrade |
| Return on Assets | Upgrade |
| Risk | |
| Beta (5Y) | Upgrade |
| Max Drawdown (5Y) | 27.87% |
Profile
| AstraZeneca Plc is a holding company, which engages in the research, development, manufacture, and commercialization of prescription medicines. The company’s history roots back to the year 1913 when Astra business was formed. AstraZeneca was founded in 1999 through the merger of Astra AB and Zeneca Group PLC. The company is headquartered in Cambridge, the United Kingdom. |
| URL | http://www.astrazeneca.com |
| Investor Relations URL | https://www.astrazeneca.com/investor-relations.html |
| HQ State/Province | Cambridgeshire |
| Sector | Health Care |
| Industry | Pharmaceuticals |
| Next Earnings Release | Feb. 10, 2026 |
| Last Earnings Release | Nov. 06, 2025 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | Aug. 08, 2025 |
Ratings
Profile
| AstraZeneca Plc is a holding company, which engages in the research, development, manufacture, and commercialization of prescription medicines. The company’s history roots back to the year 1913 when Astra business was formed. AstraZeneca was founded in 1999 through the merger of Astra AB and Zeneca Group PLC. The company is headquartered in Cambridge, the United Kingdom. |
| URL | http://www.astrazeneca.com |
| Investor Relations URL | https://www.astrazeneca.com/investor-relations.html |
| HQ State/Province | Cambridgeshire |
| Sector | Health Care |
| Industry | Pharmaceuticals |
| Next Earnings Release | Feb. 10, 2026 |
| Last Earnings Release | Nov. 06, 2025 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | Aug. 08, 2025 |